Aandelen in “Gezondheidstechnologie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Gezondheidstechnologie”

8/05 · Are RMAX, KALV, GBTG Obtaining Fair Deals for their Shareholders? · Persbericht

8/05 · Are RMAX, KALV, GBTG Obtaining Fair Deals for their Shareholders? · Persbericht

8/05 · Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

8/05 · Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026 · Persbericht

8/05 · Inhibrx To Host Webcast Presentation to Provide Clinical Update on INBRX-106 HexAgon Study in First Line HNSCC · Persbericht

8/05 · Karen Massey, de leergierige globetrotter die Argenx naar het volgend niveau loodst: ‘Arrogantie is een van de valkuilen van succesvolle bedrijven’ · Tijd.be (€)

Terwijl de wereld stormloopt voor de snelgroeiende Belgische biotechtrots Argenx pleit kersvers CEO Karen Massey voor nederigheid. Een portret van de veelzijdige Australische wereldreiziger die deze w...

8/05 · Form 8.3 - Advanced Medical Solutions Group plc - Octopus · Persbericht

8/05 · Philips shareholders approve all proposals at the AGM 2026 · Persbericht

8/05 · Co-Diagnostics Joint Venture CoMira Finalizes Lease Agreement for Manufacturing Facility in Saudi Arabia's Sudair Industrial City · Persbericht

8/05 · Atossa Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update · Persbericht

8/05 · INOVIO to Participate in Upcoming Scientific Conferences · Persbericht

8/05 · Soligenix Announces Recent Updates and First Quarter 2026 Financial Results · Persbericht

8/05 · Dimensional Fund Advisors Ltd. : Form 8.3 - ADVANCED MEDICAL SOLUTIONS - Ordinary Shares · Persbericht

8/05 · Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 07 05 2026] - (CGWL) · Persbericht

8/05 · Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer's Disease · Persbericht

8/05 · Vanda Pharmaceuticals Announces Participation at May 2026 Investor Conferences · Persbericht

8/05 · Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 · Persbericht

7/05 · SenesTech to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026 · Persbericht

7/05 · Viatris to Present at the Bank of America Securities 2026 Healthcare Conference · Persbericht

7/05 · Nektar Therapeutics Reports First Quarter 2026 Financial Results · Persbericht

7/05 · Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan · Persbericht

Mijn selecties